Biocon Limited has informed the Exchange regarding a revised press release dated August 10, 2023, titled "Biocon Q1FY24 Revenue at Rs 3,516 Cr, Up 59%; Biosimilars Up 106%; Research Services Up 25%; EBITDA at Rs 808 Cr, Up 69%; Net Profit at Rs 101 Cr".